Center for Addiction and Pregnancy: Recent Publications of CAP Program Research

Jansson L, Svikis DS, Velez M, Jones HE (2002). Impact of Managed Care on Treatment for Pregnant Drug-Dependent Women and their Children. Journal of Perinatology, 22, 5-6.

Jones HE, Svikis DS, Tran G. (2002). Relationship between patient compliance and maternal and infant outcomes in pregnant drug misusing women. Substance Use and Misuse, 37, 1411-1422.

Perry B, Jones H, Tuten M, Svikis D (2003). Assessing Maternal Perceptions of Harmful Effects of Drug Use During Pregnancy. Journal of Addictive Diseases, 22, 1-9.

Tuten M, Jones HE, Svikis DS. (2003). Comparing Homeless and Domiciled Pregnant Substance Dependent Women on Psychosocial Characteristics and Treatment Outcomes. Drug and Alcohol Dependence, 69, 95-99.

Tuten M, Jones HE. (2003). A Partner’s drug using status impacts women’s drug treatment outcome. Drug and Alcohol Dependence, 70, 327-330.

Johnson RE, Jones HE, Fischer G. (2003). Use of Buprenorphine in Pregnancy: Patient Management and Effects on the Neonate. Drug Alcohol Dependence, 70, S87-S101.

Jones H, Svikis D, Rosado J, Tuten M, Kulstad J. (2004). What If They Do Not Want Treatment?: Lessons Learned from Intervention Studies Of Non-Treatment Seeking Drug Using Pregnant Women. American Journal on Addictions, 13, 1-16.

Tuten M, Jones HE, Tran G, Svikis D. (2004). Partner Violence Impacts the Psychosocial and Psychiatric Status of Pregnant Drug Dependent Women. Addictive Behaviors, 29, 1029-1034.

Choo RE, Huestis MA, Schroeder JR, Shin AS, Jones HE. (2004). Neonatal abstinence syndrome in methadone exposed infants is altered by level of prenatal tobacco exposure. Drug and Alcohol Dependence, 75, 253-60.

Jones, HE. (2004). Practical Considerations for the Clinical Use of Buprenorphine. Science & Practice Perspectives (a National Institute on Drug Abuse peer-reviewed publication), 2, 4-20.
 
Johnson RE, Jones HE, Svikis DS, Haug N, Jansson L, Kissin WB, Alpan G, Lantz ME, Cone, EJ, Golden AS, Huggins GR, Lester B & Jasinski DR (2001). Buprenorphine induction and maintenance during pregnancy: An open-label study. Drug and
Alcohol Dependence 61.
 
Zackon PL, Jones HE, Haug NA, Kissin WB, & Svikis DS (In press). Clinical and psychosocial characteristics of substance dependent pregnant women with and without PTSD. Addictive Behaviors.
 
Jones HE, Haug N, Silverman K, Stitzer M & Svikis D (2001). The Effectiveness of incentives in enhancing treatment retention and drug abstinence in methadone-maintained pregnant women. Drug and Alcohol Dependence 61: 297-306.
 
Haug NA, Jones HE, Moylan P, Eggleston M, Laban M, & Svikis D. (2000). Accuracy of the Nicometer in detecting cotinine levels. Nicotine & Tobacco Research, 2: 295.
 
Jones HE, Haug NA, Stitzer ML & Svikis DS (2000). Improving treatment outcomes for pregnant drug-dependent women using low magnitude-voucher incentives. Addictive Behaviors 25:263-267. Jones HE & Johnson RE. (2001). Pregnancy and Substance
Misuse. Current Opinion in Psychiatry. 14: 187-193.
 
Jones HE, Velez ML, McCaul ME & Svikis DS (1999). Chapter 12- Special treatment issues for women. In: EC Strain & M Stitzer eds. Methadone Treatment for Opioid Dependence. Baltimore: Johns Hopkins University Press. pp. 251-280.
 
Jones HE & Balster RL. (1998). Inhalant abuse in pregnancy. In: JR. Woods ed. Obstetrics and Gynecology Clinics of North America. Philadelphia: W.B. Saunders Co. pp. 8-1 - 8-15